VGX Trademark

Trademark Overview

On Thursday, February 14, 2019, a trademark application was filed for VGX with the United States Patent and Trademark Office. The USPTO has given the VGX trademark a serial number of 88301628. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, March 27, 2023. This trademark is owned by Inovio Pharmaceuticals, Inc.. The VGX trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

scientific testing and analysis of cGMP (current good manufacturing practice) processes in the field of nucleic acids including DNA plasmids and of the nucleic acid molecules produced by such processes; Research and development in the pharmaceutical and biotechnology fields; Research and development of vaccines and medicines
vgx

General Information

Serial Number88301628
Word MarkVGX
Filing DateThursday, February 14, 2019
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, March 27, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 24, 2019

Trademark Statements

Goods and Servicesscientific testing and analysis of cGMP (current good manufacturing practice) processes in the field of nucleic acids including DNA plasmids and of the nucleic acid molecules produced by such processes; Research and development in the pharmaceutical and biotechnology fields; Research and development of vaccines and medicines

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, March 8, 2019
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameInovio Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressPlymouth Meeting, PA 19462
Party NameInovio Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressPlymouth Meeting, PA 19462

Trademark Events

Event DateEvent Description
Monday, March 27, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, March 27, 2023ABANDONMENT - NO USE STATEMENT FILED
Wednesday, August 31, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, August 30, 2022SOU EXTENSION 5 GRANTED
Thursday, August 18, 2022SOU EXTENSION 5 FILED
Tuesday, August 30, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, August 18, 2022SOU TEAS EXTENSION RECEIVED
Tuesday, February 22, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, February 18, 2022SOU EXTENSION 4 GRANTED
Friday, February 18, 2022SOU EXTENSION 4 FILED
Friday, February 18, 2022SOU TEAS EXTENSION RECEIVED
Friday, August 20, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, August 18, 2021SOU EXTENSION 3 GRANTED
Wednesday, August 18, 2021SOU EXTENSION 3 FILED
Wednesday, August 18, 2021SOU TEAS EXTENSION RECEIVED
Saturday, February 20, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, February 18, 2021SOU EXTENSION 2 GRANTED
Thursday, February 18, 2021SOU EXTENSION 2 FILED
Thursday, February 18, 2021SOU TEAS EXTENSION RECEIVED
Wednesday, August 19, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, August 17, 2020SOU EXTENSION 1 GRANTED
Monday, August 17, 2020SOU EXTENSION 1 FILED
Monday, August 17, 2020SOU TEAS EXTENSION RECEIVED
Tuesday, February 18, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 24, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 24, 2019PUBLISHED FOR OPPOSITION
Wednesday, December 4, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, November 15, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, November 13, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, November 13, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, November 13, 2019ASSIGNED TO LIE
Wednesday, November 6, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, May 6, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, May 6, 2019NON-FINAL ACTION E-MAILED
Monday, May 6, 2019NON-FINAL ACTION WRITTEN
Friday, April 26, 2019ASSIGNED TO EXAMINER
Friday, March 8, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, February 18, 2019NEW APPLICATION ENTERED

Related Keywords

processes nucleic research development medicines produced molecules such vaccines pharmaceutical